15 Results for "

VP1

" in MedChemExpress (MCE) Product Catalog:
Products (15)

15 Results for "VP1" in MCE Product Catalog:

1
1 Cited Publications
Cat. No.: HY-N0620
CAS No.: 102841-43-0
Mulberroside C is one of the main bioactive components in white mulberry (Morus alba L.). Mulberroside C exhibits antiplatelet, antiviral and neutrophil-regulating activities, and binds to EV-A71 VP1 with a Kd value of 1.289 nM. Mulberroside C reduces the phosphorylation level of ERK, promotes the phosphorylation of IP3RI at the Ser 1756 site, and decreases calcium influx and calcium mobilization. Mulberroside C inhibits the expression of P-selectin (P-selectin). Mulberroside C upregulates the cyclic nucleotide signaling pathway in human platelets. Mulberroside C binds to IL-23R, upregulates the expression of G-CSF, GM-CSF and RASGRP1, and activates the RAS/ERK signaling pathway. Mulberroside C promotes neutrophil maturation, accelerates the recovery of leukopenia, and enhances the antibacterial activity of neutrophils. Mulberroside C inhibits the replication of hepatitis C virus in replicon cells. Mulberroside C prevents the uncoating and genome release of EV-A71, and inhibits the synthesis of viral proteins and RNA. Mulberroside C can be used in studies related to thrombosis-mediated cardiovascular diseases, chemotherapy- and radiotherapy-induced leukopenia, hepatitis C virus infection, and hand, foot and mouth disease [1] .
loading...
    loading...
Cat. No.: HY-W019806
CAS No.: 7578-25-8
Synonyms: LNFP I
Lacto-N-fucopentaose I (LNFPI) is a human milk oligosaccharide (HMO), possessing antiviral and antibacterial activity. Lacto-N-fucopentaose I can reduce capsid protein VP1 to block virus adsorption, promote CDK2 and reduce cyclin E to recover cell cycle S phase block. Lacto-N-fucopentaose I inhibits ROS production and apoptosis in virus-infected cells. Lacto-N-fucopentaose I can also regulate intestinal microbiota to affect immune system development [1].
loading...
    loading...
Cat. No.: HY-111233
CAS No.: 87495-31-6
Synonyms: WIN-51711
Target:  

Enterovirus

Research Areas:  

Infection

Disoxaril (WIN-51711) is an antivirus agent with activity against poliovirus types 1 and 2. Disoxaril inserts into the hydrophobic interior of virus capsid protein VP1 to stabilize virion conformation, inhibits poliovirus uncoating, and prevents viral RNA release and synthesis. Disoxaril can be used for the research of poliovirus infection [1] .
loading...
    loading...
Cat. No.: HY-183010
CAS No.: 173900-00-0
VP1 ligand-1 (Scheme 1 A 1) is a VP1 ligand. VP1 ligand-1 acts as a ligand for target protein for PROTAC (Ligands for Target Protein for PROTAC) and is used for the development and design of PROTAC-based VP1 degraders, such as Jun15702 (HY-182924). VP1 ligand-1 is applicable to EV-D68 infection research [1].
loading...
    loading...
Cat. No.: HY-183014
VP1 ligand-Linker Conjugate 1 is a target protein ligand-linker conjugate that can be used for the synthesis of PROTACs, such as Jun15702 (HY-182924) [1].
loading...
    loading...
Cat. No.: HY-P991153
CAS No.: 2923558-06-7

Target:  

Virus Protease

Research Areas:  

Infection

Potravitug is a humanized immunoglobulin G1-κ monoclonal antibody targeting the major capsid protein VP1 of BK polyomavirus (BKV). Potravitug is promising for research of BKV-infection-related diseases, such as BKV-induced nephropathy after organ transplantation [1].
loading...
    loading...
Cat. No.: HY-145850
CAS No.: 2413648-96-9
Target:  

Enterovirus

Research Areas:  

Infection

EV-A71-IN-1 is a human enterovirus A71 (EV-A71) capsid protein inhibitor with an EC50 of 0.27 μM against EV-A71. EV-A71-IN-1 is a capsid binder that blocks the interaction between the viral VP1 and the host receptor hSCARB2. EV-A71-IN-1 inhibits a series of different human enteroviruses without significant cytotoxicity (CC50>56.2 μM) [1].
loading...
    loading...
Cat. No.: HY-P72307
Purity:  ≥ 90%, as determined by reducing SDS-PAGE.
Synonyms: Major capsid protein VP1; Major structural protein VP1
Species:  
Virus
Source:  
Sf9 insect cells
loading...
    loading...
Cat. No.: HY-178835
CAS No.: 314768-41-7
Target:  

Enterovirus

Research Areas:  

Infection

R523062 is a viral 2C inhibitor. R523062 reduces the viral VP1 protein. R523062 displays a broad-range antiviral activity against EV-D68 strains [1].
loading...
    loading...
Cat. No.: HY-P76280
Purity:  ≥ 85%, as determined by reducing SDS-PAGE.
Synonyms: Coxsackievirus A16 (Cox A16) (strain G-10) VP4 Protein; VP1 Protein; CV3B; 3D; VP1 (1D); VP2 (1B); VP3 (1C); VP4 (1A); protease 2A; protease 3C; protein 2C; protein 3A; protien 2B
Species:  
Virus
Source:  
Sf9 insect cells
loading...
    loading...
Cat. No.: HY-182924
Target:  

PROTACs Enterovirus

Research Areas:  

Infection

Jun15702 is a PROTAC degrader targeting the capsid protein VP1 of enterovirus D68. Jun15702 recruits the Cereblon (CRBN) E3 ligase and activates the ubiquitin-proteasome pathway. Jun15702 inhibits viral entry and exerts inhibitory effects during the early, middle and late stages of viral replication. Jun15702 exhibits antiviral activity against multiple wild-type enterovirus D68 strains, and also shows submicromolar antiviral activity against the Pleconaril (HY-19952)-resistant enterovirus D68 variant rMO-VP1 F159V. Jun15702 can be used in studies related to enterovirus D68 (EV-D68) infection [1].
loading...
    loading...
Cat. No.: HY-P75251
Purity:  ≥ 90%, as determined by reducing SDS-PAGE.
Synonyms: Enterovirus D68 (EV-D68) (strain Fermon) VP4 Protein
Species:  
Virus
Source:  
Sf9 insect cells
loading...
    loading...
Cat. No.: HY-183011
CAS No.: 2953426-96-3
Target:  

Ligands for E3 Ligase

Research Areas:  

Others

CRBN ligand-901 (5d in Scheme 2) is a ligand for Cereblon (CRBN). CRBN ligand-901 can be linked to target protein ligands (e.g., VP1 ligand-1) via a linker to form PROTAC molecules (e.g., Jun15702 (HY-182924)) [1].
loading...
    loading...
Cat. No.: HY-N16775
CAS No.: 206876-12-2
Gylongiposide I is a selective inhibitor against the enterovirus EV71 with an EC50 of 1.53 μM. Gylongiposide I exerts antiviral activity by reducing viral protein VP1 expression and viral genomic RNA levels. Gylongiposide I can be used in the development of anti-EV71 drugs related to hand, foot and mouth disease [1] .
loading...
    loading...
Cat. No.: HY-P76281
Purity:  ≥ 85%, as determined by reducing SDS-PAGE.
Synonyms: Coxsackievirus A16 (Cox A16) (strain G-10) VP4 Protein; VP1 Protein; CV3B; 3D; VP1 (1D); VP2 (1B); VP3 (1C); VP4 (1A); protease 2A; protease 3C; protein 2C; protein 3A; protien 2B
Species:  
Virus
Source:  
Sf9 insect cells
loading...
    loading...
  • 1